跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,575 条关于
“ARK Invest”
全部
8,575
临床试验
6,784
药物
509
机构
77
资讯
1,205
2个月前
Ark Invest Exits BioNTech Position Amid Revenue Decline and Leadership Transition
去年
Intellia Therapeutics Gains Momentum as ARK Invest and Institutional Investors Back CRISPR Gene Editing Platform
9个月前
Recursion Pharmaceuticals' AI-Discovered Drug REC-4881 Shows Promise in Phase 1b/2 FAP Trial
去年
CRISPR Therapeutics Faces Market Challenges Despite Casgevy Approval
10个月前
PacBio Gains China Regulatory Approval for Clinical-Grade Long-Read Sequencing System
去年
FDA Announces Shift from Animal Testing to AI Models, Boosting Recursion Pharmaceuticals Stock 20%
去年
Arcturus Therapeutics Advances mRNA Therapeutics Pipeline with Strong Financial Performance and Strategic Focus
去年
Ark Clinical Research Launches Mobile Unit to Enhance Decentralized Clinical Trials and Diversity
去年
Ark Clinical Research to Launch Mobile Unit for Decentralized Trials
去年
FDA Clears Ark Surgical's LapBox POWER: First Dual-Wall System for Both Manual and Power Morcellation
第 1 页,共 121 页
上一页
下一页